Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 2,813	$ (10,494)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	93,128	105,937
Deferred income tax provision (benefit)	603	(1,801)
Net loss (gain) on sales of property and equipment	(2,401)	2,318
Noncash compensation	7,413	8,101
Other Noncash Income (Expense)	(64)	(4,636)
Increase (Decrease) in Accounts Receivable	(130,023)	(29,587)
Excluding the effects of acquisitions, increase (decrease) in cash from:
Inventory	(14,079)	12,371
Proceeds from Sale of Debt Securities, Available-for-sale	0	4,486
Other operating assets	4,522	(7,624)
Currency translation effect on working capital, excluding cash	(4,690)	(142)
Current liabilities	14,562	14,130
Increase (Decrease) in Other Noncurrent Liabilities	(10,367)	(3,254)
Total adjustments to net income (loss)	(41,396)	95,813
Net Cash Provided by (Used in) Operating Activities	(38,583)	85,319
Cash Flows from Investing Activities:
Purchases of property and equipment	(55,094)	(35,816)
Distributions of capital from unconsolidated affiliates	540	3,108
Dispositions of property and equipment	6,422	4,129
Payments for (Proceeds from) Other Investing Activities	(3,000)	1,157
Net Cash Provided by (Used in) Investing Activities	(51,132)	(22,936)
Repayments of Senior Debt	0	(63,010)
Cash Flows from Financing Activities:
Other financing activities	(1,862)	(1,727)
Net Cash Provided by (Used in) Financing Activities	(1,862)	(64,737)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(19,030)	(1,937)
Net Increase (Decrease) in Cash and Cash Equivalents	(110,607)	(4,291)
Cash and Cash Equivalents—Beginning of Period	538,114	452,016
Cash and Cash Equivalents—End of Period	427,507	447,725
Proceeds from Sale of Debt Securities, Available-for-sale	$ 0	$ 4,486